Month: July 2024

NEW YORK, July 18, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful completion of biocompatibility testing of its Intelligent Fingerprinting Drug Screening System, a pivotal phase in the clinical study plan required for FDA 510(k) regulatory clearance. The biocompatibility study, conducted in accordance with ISO 10993 standards, involved a thorough evaluation of the system’s materials that come into contact with human skin. With the successful completion of the biocompatibility study, INBS has confirmed that all materials used in its system, including the Drug Screening Cartridge, Confirmatory Cartridge and the DSR-Plus Reader, are...

Clermont-Ferrand, July 18, 2024 COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELIN Initiation rating from Scope Ratings and upgrade from Moody’s Ratings On July 12, 2024, the European rating agency Scope Ratings published a solicited rating report on Michelin (Compagnie Générale des Etablissements Michelin and its main financial subsidiaries): long-term rating of A with a Stable outlook and short-term rating of S-1. “The issuer rating reflects Michelin’s strong business risk profile as a leading global tyre manufacturer and an even stronger financial risk profile, supported by low leverage” Scope mentioned in its press release. The agency’s rating report is available at  www.scoperatings.com On July 11, 2024, Moody’s upgraded Michelin long-term rating to A2 with a Stable Outlook, from A3 with a Stable outlook, “reflecting the group’s track...

CINCINNATI, July 18, 2024 (GLOBE NEWSWIRE) — Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today announced McAbee Trucking, Inc., a pioneer in the operation of alternative fuel trucks on Star Carrier Mail Contractor Routes, has taken a step forward in sustainable transportation by acquiring a new all-electric W4 CC box truck from Workhorse. This purchase marks McAbee Trucking’s first addition of an electric vehicle to their fleet, following a successful demonstration period that showcased the capabilities and benefits of Workhorse’s W4 CC. The decision to acquire a W4 CC was driven by the impressive performance observed during the demo, validating the reliability and efficiency of the Workhorse electric...

CAMBRIDGE, Mass., July 18, 2024 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will report its second-quarter 2024 financial results on Thursday, August 1, 2024. Vericel’s management will host a conference call and webcast at 8:30 a.m. (ET) to discuss its financial results and business highlights. The live webcast can be accessed on the Investor Relations section of the Vericel website at http://investors.vcel.com/events-presentations. Please visit the site at least 15 minutes prior to the scheduled start time in order to register and download the required audio software, if necessary. Presentation slides for the conference call will be available on the webcast and on the Investor Relations section of the Vericel...

Philadelphia, PA, July 18, 2024 (GLOBE NEWSWIRE) — – DriveItAway’s national company-owned fleet is expanding rapidly all over the country, following its recent vehicle financing agreement, requiring professional fleet management for vehicle maintenance, mechanical service, and accident management – Corporate Claims Management is one of the oldest and largest independent comprehensive fleet service and accident management companies in the US, and for 31 years has provided these services to national corporate fleets throughout the United States and Canada – This partnership with Corporate Claims Management will allow DriveItAway to quickly and seamlessly scale its company-owned fleet throughout the country, with the best driver-focused quality care, without the need to add additional overheadPHILADELPHIA, PA,...

ATCHISON, Kan., July 18, 2024 (GLOBE NEWSWIRE) — MGP Ingredients, Inc. (Nasdaq:MGPI), a leading provider of branded and distilled spirits and food ingredient solutions, today announced that it will report results for the second quarter ended June 30, 2024, on Thursday, August 1, at 10 a.m. ET. The company expects to release its financial results before the markets open. Management, including David Bratcher, CEO and president, and Brandon Gall, CFO, will hold a conference call to discuss these results. Please visit the “News and Events” section of the company’s Investor Relations section at ir.mgpingredients.com/news-events to access the live webcast. Investors can also dial 844-308-6398 (domestic) or 412-717-9605 (international) to listen to the live call. A replay will be available on the company’s website after the call concludes. About...

WILMINGTON, Del., July 18, 2024 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced that the company will release its second quarter 2024 financial results before the market open on Thursday, August 1, 2024. InterDigital executives will host a conference call that same day at 10:00 a.m. Eastern Time (ET) to discuss the company performance. For a live webcast of the conference call visit www.interdigital.com and click on the “Webcast” link on the Investors page. The company encourages participants to take advantage of the webcast option. For telephone access to the conference call, visit www.interdigital.com and click on the “Dial-In Registration” link on the Investors page. Registration is necessary to obtain a dial-in phone number and PIN to...

Nose-to-Brain Drug Delivery Shows Promising Patient Safety and Therapeutic Benefit The Device and CMC Development Master Plan is designed to support IND-enabling studies SARASOTA, FL, July 18, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced it has entered into a Device and CMC Development Master Plan with Resyca BV, a medical technology provider. Resyca is a joint venture between Bespak Group and Medspray Pharma BV which manufactures the formulation-specific microchip-based spray system chosen by Silo for its lead candidate SPC-15, an intranasal prophylactic treatment for post-traumatic stress disorder (PTSD). “The...

Falco Resources Thanks All Participants MONTREAL, July 18, 2024 (GLOBE NEWSWIRE) — Falco Resources Ltd. (TSX-V: FPC) (“Falco” or the “Corporation”) is delighted with citizen participation in the immersive public workshop which was held on July 17th at the Rouyn-Noranda Convention Center. The population was invited to experience sound and vibration simulations and meet acoustics experts. In addition to explaining the sound and vibration phenomena that surround us, the evening aimed to collect the concerns, understandings and proposals for improvement formulated by citizens regarding Falco’s Horne 5 Project. Martin Duclos, Director, Environment and Community Relations, said: “All comments will be read carefully and each question will be answered. At Falco, every opinion counts, helps fuel our thinking and plays an important role...

SANTA ANA, Calif., July 18, 2024 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer (“NK”) cell therapeutics, today announced that it will present new biomarker data on SNK01 (autologous non-genetically modified NK cell therapy) in Alzheimer’s disease during a poster presentation at the upcoming Alzheimer’s Association International Conference (“AAIC”) to be held in Philadelphia, PA at the Pennsylvania Convention Center and online from July 28 – August 1, 2024. NKGen will present data on SNK01’s ability to reduce α-synuclein in Alzheimer’s patients, which is significant given that α-synuclein has been shown to correlate with worse cognitive function...